Financhill
Sell
46

WRB Quote, Financials, Valuation and Earnings

Last price:
$58.58
Seasonality move :
6.39%
Day range:
$56.88 - $59.15
52-week range:
$46.48 - $65.49
Dividend yield:
0.54%
P/E ratio:
15.01x
P/S ratio:
1.80x
P/B ratio:
2.65x
Volume:
3.4M
Avg. volume:
1.4M
1-year change:
26.76%
Market cap:
$22.3B
Revenue:
$12.1B
EPS (TTM):
$3.90
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $7.9B $8.1B $9.5B $11.2B $12.1B
Revenue Growth (YoY) 2.78% 2.09% 17.07% 18.31% 7.97%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $409.9M $392.5M $493.3M $512.9M $535.9M
Operating Expenses $603.8M $560.9M $681.4M $735.3M $810.7M
Operating Income -- -- -- -- --
 
Net Interest Expenses $153.4M $150.5M $147.2M $130.4M $127.5M
EBT. Incl. Unusual Items $852.9M $704.8M $1.3B $1.7B $1.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $168.9M $171.8M $251.9M $334.7M $370.6M
Net Income to Company $681.9M $530.7M $1B $1.4B $1.4B
 
Minority Interest in Earnings -$2M -$2.3M -$8.5M -$3.9M -$2.5M
Net Income to Common Excl Extra Items $681.9M $530.7M $1B $1.4B $1.4B
 
Basic EPS (Cont. Ops) $1.59 $1.26 $2.46 $3.33 $3.40
Diluted EPS (Cont. Ops) $1.56 $1.25 $2.44 $3.29 $3.37
Weighted Average Basic Share $429.1M $420.6M $416.1M $415.3M $406.5M
Weighted Average Diluted Share $435.4M $424.7M $419.6M $419.2M $409.9M
 
EBITDA -- -- -- -- --
EBIT $1B $855.3M $1.4B $1.9B $1.9B
 
Revenue (Reported) $7.9B $8.1B $9.5B $11.2B $12.1B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $1B $855.3M $1.4B $1.9B $1.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2B $2.4B $2.8B $3.1B $3.4B
Revenue Growth (YoY) 2.34% 19.76% 13.49% 10.4% 10.57%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $87.6M $122.4M $119.1M $137.2M $129.2M
Operating Expenses $129.5M $166.7M $172.5M $196.9M $186.5M
Operating Income -- -- -- -- --
 
Net Interest Expenses $39.8M $35.1M $31.8M $31.9M $31.7M
EBT. Incl. Unusual Items $206.4M $332.3M $286.3M $419.9M $474.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $54M $65M $55.8M $86.5M $109.1M
Net Income to Company $151.7M $261.3M $228.9M $333.6M $365.6M
 
Minority Interest in Earnings -$688K -$6M -$1.6M $156K $320K
Net Income to Common Excl Extra Items $151.7M $261.3M $228.9M $333.6M $365.6M
 
Basic EPS (Cont. Ops) $0.36 $0.63 $0.55 $0.83 $0.92
Diluted EPS (Cont. Ops) $0.36 $0.62 $0.55 $0.82 $0.91
Weighted Average Basic Share $418M $416.3M $415.8M $403.8M $398.3M
Weighted Average Diluted Share $422.4M $420.2M $419.5M $407.2M $401.8M
 
EBITDA -- -- -- -- --
EBIT $246.2M $367.4M $318M $451.8M $506.2M
 
Revenue (Reported) $2B $2.4B $2.8B $3.1B $3.4B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $246.2M $367.4M $318M $451.8M $506.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7.8B $9.2B $10.8B $11.9B $13.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $383.1M $453.2M $520.2M $541.4M $537.5M
Operating Expenses $566M $619.7M $741.3M $799M $797.6M
Operating Income -- -- -- -- --
 
Net Interest Expenses $148.4M $145.5M $135.8M $127.5M $127M
EBT. Incl. Unusual Items $452.2M $1.3B $1.6B $1.7B $2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $111.9M $278.5M $298.6M $364.8M $459.2M
Net Income to Company $337.8M $1B $1.3B $1.4B $1.6B
 
Minority Interest in Earnings -$2.5M -$9M -$4M -$624K -$844K
Net Income to Common Excl Extra Items $337.8M $1B $1.3B $1.4B $1.6B
 
Basic EPS (Cont. Ops) $0.80 $2.49 $3.12 $3.34 $3.94
Diluted EPS (Cont. Ops) $0.80 $2.48 $3.09 $3.31 $3.90
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT $600.5M $1.5B $1.7B $1.9B $2.2B
 
Revenue (Reported) $7.8B $9.2B $10.8B $11.9B $13.2B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $600.5M $1.5B $1.7B $1.9B $2.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.8B $6.9B $8.2B $8.9B $10B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $259.4M $320.1M $347M $375.5M $377.1M
Operating Expenses $394.5M $453.3M $513.2M $576.1M $563M
Operating Income -- -- -- -- --
 
Net Interest Expenses $114.9M $109.8M $98.5M $95.6M $95.2M
EBT. Incl. Unusual Items $305.4M $928.3M $1.2B $1.3B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $84.9M $191.6M $238.3M $268.3M $357M
Net Income to Company $218.5M $728.1M $998.8M $984M $1.2B
 
Minority Interest in Earnings -$2M -$8.7M -$4.1M -$863K $780K
Net Income to Common Excl Extra Items $218.5M $728.1M $998.8M $984M $1.2B
 
Basic EPS (Cont. Ops) $0.52 $1.75 $2.41 $2.42 $2.95
Diluted EPS (Cont. Ops) $0.52 $1.73 $2.39 $2.40 $2.92
Weighted Average Basic Share $1.3B $1.2B $1.2B $1.2B $1.2B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.2B $1.2B
 
EBITDA -- -- -- -- --
EBIT $420.3M $1B $1.3B $1.3B $1.6B
 
Revenue (Reported) $5.8B $6.9B $8.2B $8.9B $10B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $420.3M $1B $1.3B $1.3B $1.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1B $2.4B $1.6B $1.4B $1.4B
Short Term Investments $14.2B $14.2B $16.6B $17.5B $20.1B
Accounts Receivable, Net $4.6B $5.1B $5.4B $6.2B $6.9B
Inventory -- -- -- -- --
Prepaid Expenses $567.6M $648.4M $676.9M $696.5M $758.9M
Other Current Assets -- -- -- -- --
Total Current Assets $20.4B $22.3B $24.3B $25.9B $29.2B
 
Property Plant And Equipment $422.1M $405.9M $419.9M $423.2M $426.8M
Long-Term Investments $16.3B $16.4B $20.2B $21.3B $23.8B
Goodwill $169.7M $169.7M $169.7M $185.5M $174.6M
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $26.7B $28.6B $32.1B $33.9B $37.2B
 
Accounts Payable $360.3M $426.1M $568.6M $523.1M $631.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $370.3M $467.4M $589.7M $562.9M $684.1M
 
Long-Term Debt $2.6B $2.7B $3.3B $2.8B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $20.5B $22.3B $25.4B $27.1B $29.7B
 
Common Stock $70.5M $70.5M $105.8M $105.8M $105.8M
Other Common Equity Adj -$257.3M -$62.2M -$282M -$1.3B -$925.8M
Common Equity $6.1B $6.3B $6.7B $6.7B $7.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $43.4M $15M $14.7M $19.8M $13.8M
Total Equity $6.1B $6.3B $6.7B $6.8B $7.5B
 
Total Liabilities and Equity $26.7B $28.6B $32.1B $33.9B $37.2B
Cash and Short Terms $15.2B $16.5B $18.2B $19B $21.5B
Total Debt $2.6B $2.7B $3.3B $2.8B $2.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $2.6B $2.1B $1.1B $1.6B $1.6B
Short Term Investments $13.9B $16.1B $17.2B $19B $22.6B
Accounts Receivable, Net $4.7B $5.5B $5.9B $6.9B $7.3B
Inventory -- -- -- -- --
Prepaid Expenses $626.2M $670.9M $701M $756.2M $830.8M
Other Current Assets -- -- -- -- --
Total Current Assets $21.9B $24.4B $25B $28.6B $32.5B
 
Property Plant And Equipment $410.2M $419.9M $414.2M $423.3M $478.4M
Long-Term Investments $16.1B $19.2B $21.2B $22.6B $26.1B
Goodwill $169.7M $169.7M $169.7M $174.6M $184.1M
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $28.2B $31.5B $33.1B $36.1B $40.4B
 
Accounts Payable $406.8M $557.5M $579.3M $626.4M $727.1M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $406.8M $557.5M $580.1M $626.4M $727.1M
 
Long-Term Debt $3.1B $3.3B $2.8B $2.8B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $22.2B $24.9B $26.7B $29.2B $31.9B
 
Common Stock $70.5M $70.5M $105.8M $105.8M $158.7M
Other Common Equity Adj -$170.9M -$190.9M -$1.4B -$1.3B -$603.1M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $44.6M $15.3M $23.9M $14.3M $13.1M
Total Equity $6B $6.7B $6.4B $6.9B $8.4B
 
Total Liabilities and Equity $28.2B $31.5B $33.1B $36.1B $40.4B
Cash and Short Terms $16.5B $18.1B $18.4B $20.6B $24.2B
Total Debt $3.1B $3.3B $2.8B $2.8B $2.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $681.9M $530.7M $1B $1.4B $1.4B
Depreciation & Amoritzation $113.4M $135.1M $129.7M $55.9M -$20.9M
Stock-Based Compensation $49.3M $49.7M $46.7M $49.4M $51M
Change in Accounts Receivable -$189.2M -$173.6M -$364.4M -$268.2M -$334.2M
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $1.6B $2.2B $2.6B $2.9B
 
Capital Expenditures $60.5M $38.2M $66.6M $52.7M $53.1M
Cash Acquisitions -- -- -- $857.2M $85M
Cash From Investing -$424.9M $119.7M -$3B -$1.9B -$2B
 
Dividends Paid (Ex Special Dividend) -$308.2M -$84.1M -$355.7M -$235.2M -$501.5M
Special Dividend Paid
Long-Term Debt Issued $291M $741.6M $1B -- --
Long-Term Debt Repaid -$456.4M -$652.8M -$505M -$429.8M -$974K
Repurchase of Common Stock -$18.2M -$346.4M -$122.4M -$94.1M -$537.2M
Other Financing Activities -$21.4M -$56.2M -$45.2M -$12.8M -$22.9M
Cash From Financing -$513.2M -$397.8M $5.8M -$772M -$1.1B
 
Beginning Cash (CF) $817.6M $1B $2.4B $1.6B $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $205.7M $1.3B -$799.3M -$94.7M -$95.2M
Ending Cash (CF) $1B $2.4B $1.6B $1.4B $1.4B
 
Levered Free Cash Flow $1.1B $1.6B $2.1B $2.5B $2.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $151.7M $261.3M $228.9M $333.6M $365.6M
Depreciation & Amoritzation $32.1M $30.7M $8.8M -$3.6M -$11.9M
Stock-Based Compensation $12.1M $13.4M $12.1M $12.7M $13.5M
Change in Accounts Receivable $28.6M -$43.4M $36.3M -$67.2M $20.8M
Change in Inventories -- -- -- -- --
Cash From Operations $557.1M $828.6M $767.7M $1.1B $1.2B
 
Capital Expenditures $8M $5.3M $13.2M $16.4M $13.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$520.8M -$638.9M -$760.5M -$1.2B -$1.1B
 
Dividends Paid (Ex Special Dividend) -$21.4M -$134.8M -$159.2M -- -$125.8M
Special Dividend Paid -- -- -- $333.3K $250K
Long-Term Debt Issued $449M $345.5M $2M $940K -$420K
Long-Term Debt Repaid -$301.3M $1.3M -- -- -$240K
Repurchase of Common Stock -$13M -$92.7M -$6.6M -$2.9M -$12.5M
Other Financing Activities -$14.3M -$21.2M -$20.4M -$20.9M -$14.9M
Cash From Financing $99M $98M -$184.2M -$22.8M -$153.8M
 
Beginning Cash (CF) $2.4B $1.8B $1.3B $1.8B $1.6B
Foreign Exchange Rate Adjustment $5.4M -$8.9M -$8.8M $3.6M $11.1M
Additions / Reductions $135.2M $287.7M -$177M -$181.1M -$18.2M
Ending Cash (CF) $2.6B $2.1B $1.1B $1.6B $1.6B
 
Levered Free Cash Flow $549.1M $823.3M $754.4M $1.1B $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $337.8M $1B $1.3B $1.4B $1.6B
Depreciation & Amoritzation $167.6M $140.2M $74.4M $13.1M -$181.1M
Stock-Based Compensation $48.7M $48.3M $46.4M $51M $53.5M
Change in Accounts Receivable -$157.9M -$363.1M -$247.1M -$360.4M -$305.9M
Change in Inventories -- -- -- -- --
Cash From Operations $1.5B $2B $2.4B $3B $3.6B
 
Capital Expenditures $89.7M $60.7M $48.3M $59.5M $102.6M
Cash Acquisitions -- -- $857.2M $94.1M -$9.1M
Cash From Investing $132.5M -$2.3B -$2.5B -$1.7B -$2.7B
 
Dividends Paid (Ex Special Dividend) -$241M -$177.4M -$381.8M -$240M -$626M
Special Dividend Paid
Long-Term Debt Issued $1B $1B $3.9M -- --
Long-Term Debt Repaid -$310.4M -$854.2M -$427.5M -- --
Repurchase of Common Stock -$330.1M -$156.9M -$6.6M -$518.1M -$342.9M
Other Financing Activities -$19.1M -$65.7M -$39M -$11.6M -$16.3M
Cash From Financing $137.8M -$227.6M -$851M -$776M -$985.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.8B -$509.8M -$917.1M $513M -$82M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.4B $1.9B $2.4B $3B $3.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $218.5M $728.1M $998.8M $984M $1.2B
Depreciation & Amoritzation $96.2M $101.3M $46M $3.3M -$157M
Stock-Based Compensation $37.8M $36.5M $36.2M $37.8M $40.3M
Change in Accounts Receivable -$175.6M -$365.1M -$247.8M -$340.1M -$311.8M
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $1.5B $1.8B $2.2B $2.9B
 
Capital Expenditures $31M $53.6M $35.3M $42.1M $91.7M
Cash Acquisitions -- -- $857.2M $94.1M --
Cash From Investing $365.5M -$2B -$1.6B -$1.4B -$2.1B
 
Dividends Paid (Ex Special Dividend) -$62.8M -$156.1M -$182.1M -$186.9M -$311.5M
Special Dividend Paid -- $222.2K $333.3K $666.7K $583.3K
Long-Term Debt Issued $747.4M $1B $2.2M $1.1M --
Long-Term Debt Repaid -$302.5M -$503.9M -$426.5M -$2M -$240K
Repurchase of Common Stock -$311.9M -$122.4M -$6.6M -$430.5M -$236.2M
Other Financing Activities -$18.5M -$27.9M -$21.8M -$20.5M -$13.9M
Cash From Financing $51.8M $222M -$634.8M -$638.9M -$561.9M
 
Beginning Cash (CF) $4.4B $6.2B $5B $4.5B $4.1B
Foreign Exchange Rate Adjustment -$6.5M -$9.2M -$26.1M $959K $1.1M
Additions / Reductions $1.6B -$294.2M -$412M $195.8M $209M
Ending Cash (CF) $6B $5.9B $4.6B $4.7B $4.3B
 
Levered Free Cash Flow $1.1B $1.5B $1.7B $2.2B $2.8B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.45% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock